Utama › Kanser Prostat › Iowa › Cedar Rapids
Kajian klinikal Kanser Prostat di Cedar Rapids, IA
12 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Cedar Rapids (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Mengambil pesertaFasa 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Mengambil pesertaFasa 3
- Univ Of Iowa Hospitals And Clinics, Iowa City · 25 mi jauh
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Mengambil pesertaFasa 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Mengambil pesertaFasa 1
- University of Iowa Health Care, Iowa City · 25 mi jauh
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Mengambil pesertaFasa 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Iowa City · 25 mi jauh
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi jauh
Preop Laxatives in Robotic Urologic Surgery
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi jauh
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Cedar Rapids
- Kanser Paru-paru Bukan Sel Kecil20 kajian
- Kanser Payudara17 kajian
- Leukemia Mieloid Akut16 kajian
- Kanser (semua jenis)15 kajian
- Mieloma Pelbagai15 kajian
- Kanser Paru-paru14 kajian
- Kanser Kolorektal13 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher12 kajian
- Melanoma10 kajian
- Strok10 kajian
- Kanser Metastatik9 kajian
- Kanser Endometrium9 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.